Abstract
Breast angiosarcoma (BAS) is an extremely rare and poorly studied neoplasm, the etiology of primary BAS remains controversial, and secondary BAS is most often radio-induced. Radio-induced breast tumors usually appear 10–20 years after the initial treatment; however, for BAS this period is much shorter and is about 4–7 years. This review presents literature data on the features of the clinic, diagnosis and treatment of BAS, as well as own clinical case observation of radio-induced sarcoma of the left breast, that developed 4 years after the primary breast cancer treatment.
Highlights
This review presents literature data on the features of the clinic, diagnosis and treatment of Breast angiosarcoma (BAS), as well as own clinical case observation of radio-induced sarcoma of the left breast, that developed 4 years after the primary breast cancer treatment
Единственным радикальным вариантом лечения данной опухоли является ее хирургическое удаление в пределах статуса краев резекции R0, однако даже в этом случае течение заболевания чрезвычайно агрессивно
Summary
Радиоиндуцированные опухоли молочной железы обычно возникают через 10–20 лет после первичного лечения рака молочной железы, однако для АСМЖ этот период существенно короче и составляет порядка 4–7 лет. Radio-induced breast angiosarcoma: features of diagnostics and treatment (a clinical case and literature review) V., Bikeev Yu. V. et al Radio-induced breast angiosarcoma: features of diagnostics and treatment (a clinical case and literature review).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.